Word

QIAGEN GENEREADER

Status

Dead

Status Code

710

Status Date

Friday, May 19, 2023

Serial Number

86017381

Registration Number

5075977

Registration Date

Tuesday, November 8, 2016

Mark Type

4000

Filing Date

Tuesday, July 23, 2013

Published for Opposition

Tuesday, August 23, 2016

Cancellation Date

Friday, May 19, 2023

Trademark Owner History

QIAGEN SCIENCES, LLC. -
QIAGEN WALTHAM, INC. -
Intelligent Bio-Systems, Inc. - Original Registrant

Classifications

9 Scientific apparatuses, instruments and devices and their structural parts and components therefor for analyzing and sequencing biomolecules, namely, nucleic acids; computer software for use in scientific and medical research for assisting in analyzing and sequencing biomolecules, namely, nucleic acids; scientific apparatuses, instruments and devices for analysis of nucleic acids, namely, nucleic acid sequencers

5 Diagnostic preparations for medical purposes; diagnostic preparations for veterinary purposes; diagnostic preparations for humans for medical purposes; preparations for medical and veterinary purposes, namely, diagnostic preparations, for sample preparation, modification and manipulation of cells and for marking, separating, isolating, purifying, duplicating, sequencing and/or for the analysis of biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances, in particular reagents, enzymes and buffer solutions for nucleic acid purification, enrichment, amplification and sequencing; chemical, biochemical and biotechnological preparations for medical and veterinary purposes, namely, diagnostic reagents, enzymes and diagnostic reagents in the nature of buffer solutions for sample preparation, modification and manipulation of cells and for marking, separating, isolating, purifying, duplicating, sequencing and/or for the analysis of biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances, in particular reagents, enzymes and buffer solutions for nucleic acid purification, enrichment, amplification and sequencing; kits containing preparations for medical and veterinary diagnostic purposes primarily consisting of diagnostic preparations for sample preparation, modification and manipulation of cells and for marking, separating, isolating, purifying, duplicating, sequencing and/or for the analysis of biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances, in particular reagents, enzymes and buffer solutions for nucleic acid purification, enrichment, amplification and sequencing

1 Chemical, biochemical and biotechnological products for industrial and scientific purposes, namely, diagnostic preparations except for human or veterinary medical purposes, non-medical chemical reagents, enzymes and chemicals solutions in the nature of buffer solutions for scientific and/or medical research use for sample preparation, modification and manipulation of cells and for marking, separating, isolating, purifying, duplicating, sequencing and/or for the analysis of biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances, in particular reagents, enzymes and buffer solutions for nucleic acid purification, enrichment, amplification and sequencing; kits comprising chemicals for laboratory or research use for sample preparation, modification and manipulation of cells and for marking, separating, isolating, purifying, duplicating, sequencing and/or for the analysis of biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances, in particular nucleic acids of biological or biochemical sample material, in particular comprising chemicals for reagents, enzymes and buffer solutions for nucleic acid purification, enrichment, amplification and sequencing

Trademark Events

May 19, 2023

Cancelled Sec. 8 (6-Yr)

Nov 8, 2021

Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed

Dec 26, 2018

Assignment Of Ownership Not Updated Automatically

May 30, 2018

Automatic Update Of Assignment Of Ownership

Aug 16, 2017

Automatic Update Of Assignment Of Ownership

Jul 27, 2017

Applicant/Correspondence Changes (Non-Responsive) Entered

Jul 27, 2017

Teas Change Of Owner Address Received

Nov 8, 2016

Registered-Principal Register

Aug 23, 2016

Official Gazette Publication Confirmation E-Mailed

Aug 23, 2016

Published For Opposition

Aug 3, 2016

Notification Of Notice Of Publication E-Mailed

Jul 19, 2016

Law Office Publication Review Completed

Jul 12, 2016

Assigned To Lie

Jul 6, 2016

Approved For Pub - Principal Register

Jun 21, 2016

Teas/Email Correspondence Entered

Jun 21, 2016

Correspondence Received In Law Office

Jun 16, 2016

Teas Response To Suspension Inquiry Received

Dec 31, 2015

Notification Of Inquiry As To Suspension E-Mailed

Dec 31, 2015

Inquiry To Suspension E-Mailed

Dec 31, 2015

Suspension Inquiry Written

Dec 9, 2015

Suspension Checked ¿ To Attorney For Action

May 27, 2015

Report Completed Suspension Check Case Still Suspended

Dec 29, 2014

Teas Change Of Correspondence Received

Nov 19, 2014

Report Completed Suspension Check Case Still Suspended

Nov 19, 2014

Suspension Checked ¿ To Attorney For Action

Oct 31, 2014

Assigned To Lie

Apr 23, 2014

Notification Of Letter Of Suspension E-Mailed

Apr 23, 2014

Letter Of Suspension E-Mailed

Apr 23, 2014

Suspension Letter Written

Apr 22, 2014

Teas/Email Correspondence Entered

Apr 21, 2014

Correspondence Received In Law Office

Apr 21, 2014

Teas Response To Office Action Received

Nov 5, 2013

Notification Of Non-Final Action E-Mailed

Nov 5, 2013

Non-Final Action E-Mailed

Nov 5, 2013

Non-Final Action Written

Nov 5, 2013

Assigned To Examiner

Jul 26, 2013

New Application Office Supplied Data Entered

Jul 26, 2013

New Application Entered